These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3857778)

  • 1. Correlation of ocular rigidity and blue sclerae in osteogenesis imperfecta.
    Kaiser-Kupfer MI; Podgor MJ; McCain L; Kupfer C; Shapiro JR
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():191-5. PubMed ID: 3857778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low ocular rigidity in patients with osteogenesis imperfecta.
    Kaiser-Kupfer MI; McCain L; Shapiro JR; Podgor MJ; Kupfer C; Rowe D
    Invest Ophthalmol Vis Sci; 1981 Jun; 20(6):807-9. PubMed ID: 7239850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of blue sclerae in osteogenesis imperfecta.
    Sillence D; Butler B; Latham M; Barlow K
    Am J Med Genet; 1993 Jan; 45(2):183-6. PubMed ID: 8456800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autosomal dominant keratoconus as the chief ocular symptom in Lobstein osteogenesis imperfecta tarda].
    Beckh U; Schönherr U; Naumann GO
    Klin Monbl Augenheilkd; 1995 Apr; 206(4):268-72. PubMed ID: 7791289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera.
    Evereklioglu C; Madenci E; Bayazit YA; Yilmaz K; Balat A; Bekir NA
    Ophthalmic Physiol Opt; 2002 Nov; 22(6):511-5. PubMed ID: 12477015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A standardized tool to measure and describe scleral colour in osteogenesis imperfecta.
    Zack P; Zack LR; Surtees R; Neville BG
    Ophthalmic Physiol Opt; 2007 Mar; 27(2):174-8. PubMed ID: 17324207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Images in clinical medicine. Blue sclerae in osteogenesis imperfecta.
    Leidig-Bruckner G; Grauer A
    N Engl J Med; 1998 Oct; 339(14):966. PubMed ID: 9753712
    [No Abstract]   [Full Text] [Related]  

  • 9. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.
    Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K
    Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations.
    Roschger P; Fratzl-Zelman N; Misof BM; Glorieux FH; Klaushofer K; Rauch F
    Calcif Tissue Int; 2008 Apr; 82(4):263-70. PubMed ID: 18311573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'BLUES' procedure for assessing the blue level of the sclera in Osteogenesis Imperfecta.
    Di Martino V; Mallone F; Lambiase A; Celli M; Mannocci A; Celli L; Mangiantini P; Fino P; Moramarco A
    Orphanet J Rare Dis; 2024 Apr; 19(1):176. PubMed ID: 38678283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic patterns in osteogenesis imperfecta.
    Wynne-Davies R; Gormley J
    Clin Orthop Relat Res; 1981 Sep; (159):26-35. PubMed ID: 7285464
    [No Abstract]   [Full Text] [Related]  

  • 13. Blue sclerae in monozygotic twins: a family study of osteogenesis imperfecta in three generations.
    Jain SC; Shrivastva DK
    Eye Ear Nose Throat Mon; 1975 Oct; 54(10):385-6. PubMed ID: 1183547
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme histochemical localisation of alkaline phosphatase activity in osteogenesis imperfecta bone and growth plate: a preliminary study.
    Sarathchandra P; Cassella JP; Ali SY
    Micron; 2005; 36(7-8):715-20. PubMed ID: 16182549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on blue sclerae in congenital osteogenesis imperfecta].
    Oerkermann H; Behnke H
    Frankf Z Pathol; 1966; 75(3):259-68. PubMed ID: 5990595
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteogenesis imperfecta with dominant inheritance and normal sclerae.
    Paterson CR; McAllion S; Miller R
    J Bone Joint Surg Br; 1983 Jan; 65(1):35-9. PubMed ID: 6822598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blue sclerae syndrome in psychiatric practice].
    Kikolska E; Tolwiński T
    Pol Tyg Lek; 1971 Oct; 26(42):1631-2. PubMed ID: 5113290
    [No Abstract]   [Full Text] [Related]  

  • 18. Instability of polymeric skin collagen in osteogenesis imperfecta.
    Francis MJ; Smith R; Bauze RJ
    Br Med J; 1974 Mar; 1(5905):421-4. PubMed ID: 4816854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenesis imperfecta: clinical, cephalometric, and biochemical investigations of OI types I, III, and IV.
    Jensen BL; Lund AM
    J Craniofac Genet Dev Biol; 1997; 17(3):121-32. PubMed ID: 9338855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.
    Vallo A; Rodriguez-Leyva F; Rodríguez Soriano J
    Acta Paediatr; 2006 Mar; 95(3):332-9. PubMed ID: 16497645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.